Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

526 public trials 91 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Active, Not Recruiting

ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia

NCT02029443

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site New Hyde Park, New York, United States
  • Research Site New York, United States
  • Research Site Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

NCT05618028

Conditions
B Cell Malignancies, Chronic Disease, Chronic Lymphocytic Leukemia, +21 more
Locations
  • University of California Los Angeles Medical Center /ID# 246357 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 259081 New Haven, Connecticut, United States
  • Mount Sinai Medical Center-Miami Beach /ID# 248251 Miami Beach, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113 Fort Wayne, Indiana, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

NCT03913949

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • Anhui Procincial hospital Hefei, Anhui, China
  • Henan Provincial Oncology Hospital Zhengzhou, Henan, China
  • Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
  • Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Active, Not Recruiting

A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain

NCT06125795

Conditions
Behavior, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • HUA - Txagorritxu /ID# 258263 Vitoria-Gasteiz, Alava, Spain
  • Sant Joan de Deu de Manresa /ID# 258266 Manresa, Barcelona, Spain
  • Hospital Universitari Mútua Terrassa /ID# 258267 Terrassa, Barcelona, Spain
  • Hospital Jerez De La Frontera /ID# 258282 Jerez de la Frontera, Cadiz, Spain
View all 25 locations
View Trial Details
Active, Not Recruiting

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT04666038

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Southern Cancer Center, P.C. Daphne, Alabama, United States
  • Mitchell Cancer Institute -University of South Alabama Mobile, Alabama, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
View all 232 locations
View Trial Details
Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details

Related conditions